SCHEMBL257611

SCHEMBL257611

Cc1ccc(-c2ccc(-c3ccccc3)c(F)c2)cc1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.53
AKR1C2 P52895 3/20 0.53
AKR1C4 P17516 2/20 0.50
AKR1C1 Q04828 2/20 0.50
AKR1B10 O60218 1/20 0.50
PTGS1 P23219 3/20 0.46
LMNA P02545 3/20 0.46
MEN1 O00255 2/20 0.46
PTGS2 P35354 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 2/20 0.46
FABP2 P12104 1/20 0.46
TSHR P16473 1/20 0.46
ADRA2B P18089 1/20 0.46
CHRM3 P20309 1/20 0.46
HTR2C P28335 1/20 0.46
DRD3 P35462 1/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23173084 0.88 AKR1C3 (0.58) AKR1C3AKR1C2AKR1C4AKR1C1AKR1B10
SCHEMBL30180898 0.88 ACHE (0.48) AKR1C3AKR1C2MAPTESR2SMN1; SMN2
SCHEMBL6172557 0.88 ACHE (0.48) AKR1C3AKR1C2MAPTESR2SMN1; SMN2
SCHEMBL13703908 0.88 AKR1C3 (0.58) AKR1C3AKR1C2AKR1C4AKR1C1AKR1B10
SCHEMBL19400433 0.88 MEN1 (0.50) AKR1C3AKR1C2AKR1C4AKR1C1PTGS1
SCHEMBL803238 0.86 AKR1C3 (0.50) AKR1C3AKR1C2AKR1C4AKR1C1AKR1B10
SCHEMBL15077185 0.86 PTGS1 (0.49) AKR1C3AKR1C2AKR1C4AKR1C1PTGS1
SCHEMBL2140807 0.86 PTGS1 (0.49) AKR1C3AKR1C2AKR1C4AKR1C1PTGS1
SCHEMBL28566500 0.86 PTGS1 (0.49) AKR1C3AKR1C2AKR1C4AKR1C1PTGS1
SCHEMBL10091190 0.85 MAPT (0.49) AKR1C3AKR1C2AKR1C4AKR1C1PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2399585-A1 Boronic acids and esters as inhibitors of fatty acid amide hydrolase Infinity Pharmaceuticals, Inc. (US) 2011-12-28 EP disclosed